Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer (Q34108152)

31 July 2017

1 reference

title

Fertility and the impact of systemic therapy on hormonal status following treatment for breast cancer (English)

1 reference

31 July 2017

1 reference

Moore HC

1

1 reference

31 July 2017

publication date

1 November 2000

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

587-593

1 reference

Early menopause in long-term survivors of cancer during adolescence

31 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-000-0114-9

Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-000-0114-9

Risk of menopause during the first year after breast cancer diagnosis

21 January 2018

1 reference

12 December 2020

Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 1: Defining the problem. Proceedings of a conference held at the Boar's Head Inn Charlottesville, Virginia. September 21-23, 1997

1 reference

12 December 2020

Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer

1 reference

12 December 2020

Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients

1 reference

12 December 2020

Pregnancy after breast-conserving surgery and radiation therapy for breast cancer.

1 reference

12 December 2020

Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up

1 reference

12 December 2020

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

12 December 2020

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results

1 reference

12 December 2020

Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

1 reference

12 December 2020

The relationship of gonadal activity and chemotherapy-induced gonadal damage

1 reference

12 December 2020

Breast cancer in young women: effect of chemotherapy on ovarian function, fertility, and birth defects

1 reference

12 December 2020

The Milan experience with adjuvant chemotherapy in premenopausal breast cancer

1 reference

12 December 2020

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications

1 reference

12 December 2020

Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy

1 reference

12 December 2020

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

1 reference

12 December 2020

Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival

1 reference

12 December 2020

Fertility and pregnancy after treatment for cancer during childhood or adolescence

1 reference

12 December 2020

Risk of cancer among offspring of childhood-cancer survivors. Association of the Nordic Cancer Registries and the Nordic Society of Paediatric Haematology and Oncology.

1 reference

12 December 2020

Influence of prior and subsequent pregnancy on breast cancer prognosis

1 reference

12 December 2020

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

12 December 2020

Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. The Cancer and Leukemia Group B

1 reference

12 December 2020

Should women be advised against pregnancy after breast-cancer treatment?

1 reference

12 December 2020

Reproductive technologies 1998: options available for the cancer patient

1 reference

12 December 2020

The role of reproductive and menstrual factors in cancer of the breast before and after menopause.

1 reference

12 December 2020

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

12 December 2020

Estrogen replacement therapy after localized breast cancer: clinical outcome of 319 women followed prospectively

1 reference

12 December 2020

Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer

1 reference

12 December 2020

Postmenopausal hormone therapy and mortality.

1 reference

12 December 2020

VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention

1 reference

12 December 2020

10.1007/S11912-000-0114-9

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1051881960

0 references

1 reference